Drug or treatment

Belantamab clinical trials

• 14Clinical trials
• 25Countries

Newest trials

All recruiting trials (14)

• Belantamab Mafodotin or Daratumumab with VRd for Newly Diagnosed High-Risk Myeloma

  This study tests whether belantamab mafodotin plus standard multiple myeloma drugs works better than daratumumab plus the same drugs for people newly diagnosed and ineligible for transplant.

  Recruiting Phase 3 PrECOG, LLC. · La Crosse, Wisconsin · NCT07285239

• Belantamab mafodotin with standard myeloma medicines for relapsed or refractory multiple myeloma

  This study tests whether giving belantamab mafodotin less often together with standard myeloma medicines helps adults whose multiple myeloma has come back or stopped responding.

  Recruiting at 59 sites Phase 2 GlaxoSmithKline · Los Alamitos, California and 58 other locations · NCT07227311

• Belantamab Mafodotin with a chemotherapy combo for newly diagnosed AL amyloidosis

  This study tests whether adding belantamab mafodotin to a regimen of cyclophosphamide, bortezomib, and dexamethasone can help adults with newly diagnosed AL amyloidosis.

  Recruiting at 16 sites Phase 2 GlaxoSmithKline · Los Angeles, California and 15 other locations · NCT07224672

• Comparing two treatment combinations for newly diagnosed multiple myeloma patients who can't undergo stem cell transplantation

  This study is testing if a new combination of medications can help people with newly diagnosed multiple myeloma who can't have a stem cell transplant live longer without their disease getting worse compared to a different treatment combination.

  Recruiting at 181 sites Phase 3 GlaxoSmithKline · Mobile, Alabama and 180 other locations · NCT06679101

• Isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone combination for relapsed/refractory multiple myeloma

  This trial tries the combination of isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone to see if it can reduce multiple myeloma in adults whose disease has returned or stopped responding to prior treatment.

  Recruiting at 2 sites Phase 2 Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT05922501

• Combining belantamab mafodotin and venetoclax for treating relapsed multiple myeloma

  This study is testing a new combination of two drugs, belantamab mafodotin and venetoclax, to see if it helps adults with relapsed multiple myeloma that has a specific genetic change.

  Recruiting at 5 sites Phase 1/2 Universitätsklinikum Hamburg-Eppendorf · Hamburg, Ham and 4 other locations · NCT05853965

• Testing different doses and schedules of belantamab mafodotin for treating tough cases of multiple myeloma

  This study is testing different doses and schedules of a new cancer treatment called belantamab mafodotin to see if it helps people with tough cases of multiple myeloma feel better and live longer.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT05847569

• Combination treatment for relapsed multiple myeloma

  This study is testing a new combination treatment for people with relapsed multiple myeloma who haven't had success with standard therapies to see if it helps them feel better.

  Recruiting at 2 sites Phase 2 University of Chicago · Chicago, Illinois and 1 other locations · NCT05789303

• Investigating Belantamab for treating Multiple Myeloma

  This study is testing a new treatment called belantamab, both by itself and with another drug, to see if it can help people with hard-to-treat multiple myeloma feel better.

  Recruiting at 39 sites Phase 1/2 GlaxoSmithKline · Bullhead City, Arizona and 43 other locations · NCT05714839

• Combination treatment for high-risk myeloma using belantamab mafodotin, pomalidomide, and dexamethasone

  This study is testing a new combination of three medications to see if it can help people with high-risk plasma cell myeloma feel better and improve their treatment outcomes.

  Recruiting Phase 2 Emory University · Atlanta, Georgia · NCT05208307

• Testing Belantamab Mafodotin for AL Amyloidosis

  This study is testing a new drug called Belantamab Mafodotin to see if it can safely help people with relapsed or hard-to-treat AL Amyloidosis feel better.

  Recruiting at 2 sites Phase 1/2 University of Texas Southwestern Medical Center · Nashville, Tennessee and 2 other locations · NCT05145816

• Using belantamab mafodotin and lenalidomide for maintenance therapy after stem cell transplant in multiple myeloma patients

  This study is testing if a combination of two medications, belantamab mafodotin and lenalidomide, can help people with multiple myeloma stay healthy longer after their stem cell transplant by reducing the cancer in their bodies.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT05091372

• Using Belantamab Mafodotin to treat high-risk smoldering multiple myeloma

  This study is testing a new treatment called Belantamab Mafodotin to see if it is safe and effective for people with high-risk smoldering multiple myeloma.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT05055063

• Combination treatment for multiple myeloma using new and standard drugs

  This study is testing a new combination of treatments for multiple myeloma to see if it can help newly diagnosed, high-risk patients feel better and improve their outcomes.

  Recruiting at 2 sites Phase 1/2 Wake Forest University Health Sciences · Charlotte, North Carolina and 1 other locations · NCT04822337

Quick answers

How many clinical trials of Belantamab are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 25 countries. The most sites are in United States (13 trials), Germany (3 trials), Japan (3 trials), South Korea (3 trials), Australia (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 7, Phase 1/2: 4, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →